InMed Pharmaceuticals Non-GAAP EPS of -$1.94, revenue of $1.26M
2025-05-12 18:02:51 ET
More on InMed Pharmaceuticals
- InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
- Financial information for InMed Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
InMed Pharmaceuticals Non-GAAP EPS of -$1.94, revenue of $1.26MNASDAQ: INM
INM Trading
123.81% G/L:
$1.555 Last:
73,877,530 Volume:
$1.79 Open:










